Akut limfoid leukémia (ALL): vizsgálatok itt: Dél-Korea
17 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Busan, Jeollanam, Seoul, Uijeongbu-si
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Seoul
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Seoul
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 1/2. fázisTaking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Seoul
- Életkor
- 12 év and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - 1/2. fázisTaking peopleSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
- Where
- Seoul
- Életkor
- 1 év to 30 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07387926 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Seoul
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - No phaseTaking peopleLong-term Follow up Local Registry Study of Kymriah in South Korea
- Where
- Bundang Gu, Busan, Gyeonggi-do, Incheon, Jeollanam, Seongnam-si, Seoul, Ulsan
- Életkor
- 0 év to 100 év
- People
- 500
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06785818 - 2. fázisTaking peopleEvaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia
- Where
- Daegu, Daejeon, Hwasun, Jeju City, Seoul, Yangsan
- Életkor
- 1 év to 22 év
- People
- 90
- Run by
- Ho Joon Im
See details and how to joinNCT05827549 - 2. fázisTaking peopleTreatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
- Where
- Daegu, Daejeon, Hwasun, Jeju City, Seongnam, Seoul, Suwon, Yangsan
- Életkor
- 1 év to 9 év
- People
- 116
- Run by
- Hee Young Ju
See details and how to joinNCT06099366 - 2. fázisTaking peopleTreatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
- Where
- Incheon, Seoul, Suwon, Yangsan
- Életkor
- 1 év to 19 év
- People
- 370
- Run by
- Jae Wook Lee
See details and how to joinNCT06184009 - 2. fázisTaking peopleTreatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
- Where
- Daegu, Daejeon, Hwasun, Jeju City, Seoul, Yangsan
- Életkor
- 1 év to 19 év
- People
- 74
- Run by
- Hyoung Jin Kang
See details and how to joinNCT06257394 - 1/2. fázisTaking peopleStudy of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 91
- Run by
- Curocell Inc.
See details and how to joinNCT04836507 - 3. fázisTaking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Busan, Seoul, Uijeongbu-si
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Hwasun, Seoul
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleVenetoclax and Decitabine in R/R T-ALL
- Where
- Seongnam-si, Seoul
- Életkor
- 19 év to 80 év
- People
- 28
- Run by
- Seoul National University Hospital
See details and how to joinNCT06712121 - No phaseTaking peopleMulticenter Study on Rehabilitation Medical Data for Pediatric Big Brain Development
- Where
- Seongnam-si
- Életkor
- Up to 20 év
- People
- 2000
- Run by
- Bundang CHA Hospital
See details and how to joinNCT06367920 - 2. fázisTaking peopleTreatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
- Where
- Seoul
- Életkor
- Up to 25 év
- People
- 50
- Run by
- Seoul National University Hospital
See details and how to joinNCT06247501